Resultados de procura - Abhishek Tripathi
- Mostrando 1 - 20 Resultados de 23
- Go to Next Page
-
1
-
2
Differential Protein Kinase C-dependent Modulation of Kv7.4 and Kv7.5 Subunits of Vascular Kv7 Channels por Lioubov I. Brueggemann, Alexander R Mackie, Leanne L. Cribbs, Jessica Freda, Abhishek Tripathi, Matthias Majetschak, Kenneth L. Byron
Publicado 2013Artigo -
3
Kv7.5 Potassium Channel Subunits Are the Primary Targets for PKA-Dependent Enhancement of Vascular Smooth Muscle Kv7 Currents por Bharath K. Mani, Christina Robakowski, Lyubov I. Brueggemann, Leanne L. Cribbs, Abhishek Tripathi, Matthias Majetschak, Kenneth L. Byron
Publicado 2015Artigo -
4
Combined use of expression and CGH arrays pinpoints novel candidate genes in Ewing sarcoma family of tumors por Suvi Savola, Arto Klami, Abhishek Tripathi, Tarja Niini, Massimo Serra, Piero Picci, Samuel Kaski, Diana Zambelli, Katia Scotlandi, Sakari Knuutila
Publicado 2009Artigo -
5
-
6
Heteromerization of chemokine (C-X-C motif) receptor 4 with α<sub>1A/B</sub>-adrenergic receptors controls α<sub>1</sub>-adrenergic receptor function por Abhishek Tripathi, P. Geoff Vana, Tanmay Chavan, Lioubov I. Brueggemann, Kenneth L. Byron, Nadya I. Tarasova, Brian F. Volkman, Vadim Gaponenko, Matthias Majetschak
Publicado 2015Artigo -
7
Adjuvant Everolimus in Non–Clear Cell Renal Cell Carcinoma por Shuchi Gulati, Catherine M. Tangen, Christopher W. Ryan, Ulka N. Vaishampayan, Brian Shuch, Pedro C. Barata, Deepak Pruthi, Cristiane Decat Bergerot, Abhishek Tripathi, Seth P. Lerner, Ian M. Thompson, Primo N. Lara, Sumanta K. Pal
Publicado 2024Artigo -
8
Metabolic Regulation in Progression to Autoimmune Diabetes por Marko Sysi‐Aho, Andrey Ermolov, Peddinti Gopalacharyulu, Abhishek Tripathi, Tuulikki Seppänen‐Laakso, Johanna Maukonen, Ismo Mattila, Suvi T. Ruohonen, Laura H. Vähätalo, Laxman Yetukuri, Taina Härkönen, Erno Lindfors, Janne Nikkilä, Jorma Ilonen, Olli Simell, Maria Saarela, Mikael Knip, Samuel Kaski, Eriika Savontaus, Matej Orešič
Publicado 2011Artigo -
9
Changes in Perception of Cure Among Patients With Genitourinary Cancers Initiating Immune Checkpoint Inhibitors: A Longitudinal Study por Cristiane Decat Bergerot, Errol J. Philip, Ameish Govindarajan, Daniela V. Castro, Jasnoor Malhotra, Paulo Gustavo Bergerot, Sabrina Salgia, Meghan Salgia, Nicholas Salgia, Joann Hsu, Luís Meza, Zeynep Büşra Zengin, Sandy Liu, Alex Chehrazi‐Raffle, Abhishek Tripathi, Tanya B. Dorff, Sumanta K. Pal
Publicado 2023Artigo -
10
Racial and ethnic differences in perceptions of germline or somatic <scp>DNA</scp> sequencing among patients with advanced prostate, urothelial, or kidney cancer por Cristiane Decat Bergerot, Errol J. Philip, Jasnoor Malhotra, Paulo Gustavo Bergerot, Daniela V. Castro, Ameish Govindarajan, Sabrina Salgia, Meghan Salgia, Nicholas Salgia, Joann Hsu, Luís Meza, Zeynep Büşra Zengin, Sandy Liu, Alex Chehrazi‐Raffle, Abhishek Tripathi, Tanya B. Dorff, Sumanta K. Pal
Publicado 2023Artigo -
11
Prevalence of Dietary Modification and Supplement Use in Patients with Metastatic Renal Cell Carcinoma Receiving Systemic Therapy por Hedyeh Ebrahimi, Dena Battle, Nicholas Salgia, Zeynep Büşra Zengin, Nazlı Dizman, Luís Meza, Cristiane Decat Bergerot, Regina Barragán-Carrillo, Joann Hsu, Daniela V. Castro, Benjamin Mercier, Neal Shiv Chawla, Xiaochen Li, Abhishek Tripathi, Sandy Liu, Alex Chehrazi‐Raffle, Ulka N. Vaishampayan, Michael Staehler, Sumanta K. Pal
Publicado 2024Artigo -
12
Barriers to Clinical Trial Implementation Among Community Care Centers por Hedyeh Ebrahimi, Sandra Megally, Elana Plotkin, Latha Shivakumar, Nicholas Salgia, Zeynep Büşra Zengin, Luís Meza, Neal Shiv Chawla, Daniella V. Castro, Nazlı Dizman, Ruma Bhagat, Seila Liv, Xiaochen Li, Adam Rock, Sandy Liu, Abhishek Tripathi, Tanya B. Dorff, Randall A. Oyer, Leigh Boehmer, Sumanta K. Pal, Alex Chehrazi‐Raffle
Publicado 2024Artigo -
13
Eligibility Criteria in Advanced Urothelial Cancer Clinical Trials: An Assessment of Modernization and Inclusion por Benjamin Mercier, Ameish Govindarajan, Daniela V. Castro, Xiaochen Li, Errol J. Philip, Matthew I. Feng, Sweta R. Prajapati, Elyse H. Chan, Kyle O. Lee, Ishaan Sehgal, Jalen Patel, Anna O'Dell, Alex Chehrazi‐Raffle, Hedyeh Ebrahimi, Adam Rock, Zeynep Büşra Zengin, Luís Meza, Nazlı Dizman, Joann Hsu, Sandy Liu, Tanya B. Dorff, Sumanta K. Pal, Abhishek Tripathi
Publicado 2025Artigo -
14
Assessment of eligibility criteria in renal cell carcinoma trials evaluating systemic therapy por Daniela V. Castro, Sweta R. Prajapati, Matthew I. Feng, Elyse H. Chan, Kyle O. Lee, Trishita Paul, Ishaan Sehgal, Jalen Patel, Xiaochen Li, Zeynep Büşra Zengin, Hedyeh Ebrahimi, Ameish Govindarajan, Luís Meza, Benjamin Mercier, Neal Shiv Chawla, Nazlı Dizman, Errol J. Philip, Joann Hsu, Cristiane Decat Bergerot, Alex Chehrazi‐Raffle, Adam Rock, Sandy Liu, Abhishek Tripathi, Tanya B. Dorff, Sumanta K. Pal
Publicado 2023Artigo -
15
Randomized Phase II Study Evaluating the Addition of Pembrolizumab to Radium-223 in Metastatic Castration-resistant Prostate Cancer por Atish D. Choudhury, Lucia Kwak, Alexander Cheung, Kathryn M. Allaire, Jaqueline Marquez, David D. Yang, Abhishek Tripathi, Jacqueline M. Kilar, Meredith Flynn, Brianna Maynard, Rebecca Reichel, Amanda F. Pace, Brandon K. Chen, Eliezer M. Van Allen, Kerry L. Kilbridge, Xiao X. Wei, Bradley A. McGregor, Mark M. Pomerantz, Rupal S. Bhatt, Christopher J. Sweeney, Glenn J. Bubley, Heather A. Jacene, Mary‐Ellen Taplin, Franklin W. Huang, Lauren C. Harshman, Lawrence Fong
Publicado 2024Artigo -
16
Cabozantinib and nivolumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial por Hedyeh Ebrahimi, Nazlı Dizman, Luís Meza, Jasnoor Malhotra, Xiaochen Li, Tanya B. Dorff, Paul Frankel, Marian Llamas-Quitiquit, Joann Hsu, Zeynep Büşra Zengin, Marice Alcantara, Daniela V. Castro, Benjamin Mercier, Neal Shiv Chawla, Alex Chehrazi‐Raffle, Regina Barragán-Carrillo, Salvador Jaime‐Casas, Ameish Govindarajan, John D. Gillece, Jeffrey M. Trent, Peter P. Lee, Thomas P. Parks, Motomichi Takahashi, Atsushi Hayashi, Marcin Kortylewski, J. Gregory Caporaso, Keehoon Lee, Abhishek Tripathi, Sumanta K. Pal
Publicado 2024Artigo -
17
Histological Subtypes and Response to PD-1/PD-L1 Blockade in Advanced Urothelial Cancer: A Retrospective Study por Natalie Miller, Ali Raza Khaki, Leonidas Nikolaos Diamantopoulos, Mehmet Asım Bilen, Víctor Sacristán Santos, Neeraj Agarwal, Rafael Morales‐Barrera, Michael Devitt, Ariel Ann Nelson, Christopher Hoimes, Evan Shreck, Hussein Assi, Benjamin A. Gartrell, Alex Sankin, Alejo Rodríguez‐Vida, Mark P. Lythgoe, David J. Pinato, Alexandra Drakaki, Monika Joshi, Pedro Isaacsson Velho, Noah M. Hahn, Sandy Liu, Lucía Alonso Buznego, Ignacio Durán, Marcus W. Moses, Jayanshu Jain, Jure Murgić, Pedro Barata, Abhishek Tripathi, Yousef Zakharia, Matthew D. Galsky, Guru Sonpavde, Evan Y. Yu, Gary H. Lyman, Petros Grivas
Publicado 2020Artigo -
18
Impact of performance status on treatment outcomes: A real‐world study of advanced urothelial cancer treated with immune checkpoint inhibitors por Ali Raza Khaki, Ang Li, Leonidas Nikolaos Diamantopoulos, Mehmet Asım Bilen, Víctor Sacristán Santos, John Esther, Rafael Morales-Bárrera, Michael Devitt, Ariel Ann Nelson, Christopher Hoimes, Evan Shreck, Hussein Assi, Benjamin A. Gartrell, Alex Sankin, Alejo Rodríguez‐Vida, Mark P. Lythgoe, David J. Pinato, Alexandra Drakaki, Monika Joshi, Pedro Isaacsson Velho, Noah M. Hahn, Sandy Liu, Lucía Alonso Buznego, Ignacio Durán, Marcus Marie Moses, Jayanshu Jain, Jure Murgić, Praneeth Baratam, Pedro Barata, Abhishek Tripathi, Yousef Zakharia, Matthew D. Galsky, Guru Sonpavde, Evan Y. Yu, Veena Shankaran, Gary H. Lyman, Petros Grivas
Publicado 2019Artigo -
19
Cabozantinib in advanced non-clear-cell renal cell carcinoma: a multicentre, retrospective, cohort study por Nieves Martínez Chanzá, Wanling Xie, Mehmet Asım Bilen, Hannah Dzimitrowicz, Jarred Burkart, Daniel M. Geynisman, Archana Balakrishnan, I. Alex Bowman, Rohit Jain, Walter M. Stadler, Yousef Zakharia, Vivek Narayan, Benoit Beuselinck, Rana R. McKay, Abhishek Tripathi, Russell K. Pachynski, Andrew W. Hahn, JoAnn Hsu, Sumit Shah, Elaine T. Lam, Tracy L. Rose, Anthony Mega, Nicholas J. Vogelzang, Michael R. Harrison, Amir Mortazavi, Elizabeth R. Plimack, Ulka N. Vaishampayan, Hans J. Hammers, Saby George, Naomi B. Haas, Neeraj Agarwal, Sumanta K. Pal, Sandy Srinivas, Benedito A. Carneiro, Daniel Y.C. Heng, Dominick Bossé, Toni K. Choueiri, Lauren C. Harshman
Publicado 2019Artigo -
20
A New Prognostic Model in Patients with Advanced Urothelial Carcinoma Treated with First-line Immune Checkpoint Inhibitors por Ali Raza Khaki, Ang Li, Leonidas Nikolaos Diamantopoulos, Natalie Miller, Lucía Carril-Ajuria, Daniel Castellano, Ivan de Kouchkovsky, Vadim S. Koshkin, Joseph J. Park, Ajjai Alva, Mehmet Asım Bilen, Tyler F. Stewart, Víctor Sacristán Santos, Neeraj Agarwal, Jayanshu Jain, Yousef Zakharia, Rafael Morales-Bárrera, Michael Devitt, Ariel Ann Nelson, Christopher Hoimes, Evan Shreck, Benjamin A. Gartrell, Alex Sankin, Abhishek Tripathi, Roubini Zakopoulou, Aristotelis Bamias, Alejo Rodríguez‐Vida, Alexandra Drakaki, Sandy Liu, Vivek Kumar, Mark P. Lythgoe, David J. Pinato, Jure Murgić, Ana Fröbe, Monika Joshi, Pedro Isaacsson Velho, Noah M. Hahn, Lucía Alonso Buznego, Ignacio Durán, Marcus W. Moses, Pedro C. Barata, Matthew D. Galsky, Guru Sonpavde, Evan Y. Yu, Veena Shankaran, Gary H. Lyman, Petros Grivas
Publicado 2021Artigo
Ferramentas de procura:
Materias Relacionadas
Medicine
Internal medicine
Oncology
Cancer
Biology
Bladder cancer
Cohort
Immunotherapy
Renal cell carcinoma
Cell biology
Retrospective cohort study
Biochemistry
Clinical trial
Confidence interval
Endocrinology
Gastroenterology
Gene
Genetics
Hazard ratio
Proportional hazards model
Receptor
Urothelial cancer
Bone metastasis
Cabozantinib
Cancer research
Chemotherapy
Cytoplasm
Disease
Ipilimumab
Metastatic Urothelial Carcinoma